Drug Profile
Research programme: infectious disease therapeutics - Spotlight Innovation
Latest Information Update: 28 Jan 2021
Price :
$50
*
At a glance
- Originator Florida State University
- Developer Spotlight Innovation
- Class Antivirals; Neuroprotectants
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Zika virus infection